Investment in Hyperthermics’ process to turn biowaste into energy and proteins
Farvatn Private Equity and Måsøval Eiendom have invested in the Norwegian biotechnology company Hyperthermics AS.…
Farvatn Private Equity and Måsøval Eiendom have invested in the Norwegian biotechnology company Hyperthermics AS.…
The immuno-oncology startup Cytovation has raised €17.7M (NOK 180M) in one of Norway's biggest Series…
Norway has not typically been an attractive region for biotech investors, so when Masha Strømme…
In Norway’s capital city of Oslo, the biotech Bio-Me can rapidly screen for specific gut…
Targovax has obtained positive Phase I/II results showing its pancreatic cancer vaccine improved the survival…
Cytovation has raised over €3M to finish off pre-clinical testing of its treatment for warts, and…
Hadean Ventures has closed its first fund, which it will begin to invest in life…
Researchers in Norway have found that a drug used to kill parasites like tapeworms can…
PCI Biotech's T cell-stimulating vaccine enhances the cellular immune response, supporting it as a candidate…
This week we're traveling to Bergen, a beautiful coastal city in Norway surrounded by seven…
We talked to CEO Øystein Soug and CMO Magnus Jäderberg of Targovax about why the…
Targovax has raised €21M (NOK200M) in a private placement, which the biotech will use to…